Cytokine gene polymorphisms in psoriasis

被引:67
作者
Craven, NM
Jackson, CW
Kirby, B
Perrey, C
Pravica, V
Hutchinson, IV
Griffiths, CEM [1 ]
机构
[1] Univ Manchester, Hope Hosp, Dermatol Ctr, Salford M6 8HD, Lancs, England
[2] Univ Manchester, Dept Immunol, Manchester, Lancs, England
关键词
interferon-gamma; interleuliin-10; interleukin-4; psoriasis; Th1; Th2;
D O I
10.1046/j.1365-2133.2001.04143.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Cytokine production is under genetic control, and certain allelic variants of cytokine genes are associated with higher or lower cytokine production in vitro and in vivo. Psoriasis is associated with an overexpression in the involved skin of T-helper cell type 1 (Th1) cytokines, e.g. interferon (IFN) -gamma and tumour necrosis factor (TNF) alpha and relative underexpression of Th2 cytokines, e.g. interleukin (IL) -4 and IL-10. Objective We investigated the hypothesis that allelic variants of genes for a high production of Th1 cytokines or TNF-alpha, or conversely low production of Th2 cytokines might represent a risk factor for developing psoriasis. Methods Genotyping for IFN-gamma, IL-10, IL-4 and TNF-alpha was undertaken for 84 patients with psoriasis and compared with control data on file. Results Genotype frequencies showed no differences between patients and controls for IFN-gamma, TNF-alpha or IL-4. For IL-10, patients with late onset psoriasis (over 40 years) were more likely to be heterozygous at position - 1082 (P = 0.02), corresponding to intermediate production of IL-10 in vitro and in vivo. Conclusions Psoriasis is not determined by a genotype consistent with high production of Th1 cytokines or low production of Th2 cytokines. Thus, the Th1 cytokine profile found in psoriatic plaques is most likely a consequence of local factors.
引用
收藏
页码:849 / 853
页数:5
相关论文
共 43 条
  • [1] Arias AI, 1997, EXP CLIN IMMUNOGENET, V14, P118
  • [2] Interleukin 10 treatment of psoriasis -: Clinical results of a phase 2 trial
    Asadullah, K
    Döcke, WD
    Ebeling, M
    Friedrich, M
    Belbe, G
    Audring, H
    Volk, HD
    Sterry, W
    [J]. ARCHIVES OF DERMATOLOGY, 1999, 135 (02) : 187 - 192
  • [3] Genotypic variation in the transforming growth factor-β1 gene -: Association with transforming growth factor-pi production, fibrotic lung disease, and graft fibrosis after lung transplantation
    Awad, MR
    El-Gamel, A
    Hasleton, P
    Turner, DM
    Sinnott, PJ
    Hutchinson, IV
    [J]. TRANSPLANTATION, 1998, 66 (08) : 1014 - 1020
  • [4] THE ROLE OF THE IMMUNE-SYSTEM IN THE PATHOGENESIS OF PSORIASIS
    BAADSGAARD, O
    FISHER, G
    VOORHEES, JJ
    COOPER, KD
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 95 (05) : S32 - S34
  • [5] THE PATHOPHYSIOLOGY OF PSORIASIS
    BARKER, JNWN
    [J]. LANCET, 1991, 338 (8761) : 227 - 230
  • [6] CORRELATED INCREASES OF TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN-6 AND GRANULOCYTE-MONOCYTE COLONY-STIMULATING FACTOR LEVELS IN SUCTION BLISTER FLUIDS AND SERA OF PSORIATIC PATIENTS - RELATIONSHIPS WITH DISEASE SEVERITY
    BONIFATI, C
    CARDUCCI, M
    FEI, PC
    TRENTO, E
    SACERDOTI, G
    FAZIO, M
    AMEGLIO, F
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1994, 19 (05) : 383 - 387
  • [7] RESPONSE TO TUMOR-NECROSIS-FACTOR IN 2 CASES OF PSORIASIS
    CREAVEN, PJ
    STOLL, HL
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 24 (05) : 735 - 737
  • [8] REAPPRAISAL OF IN-SITU IMMUNOPHENOTYPIC ANALYSIS OF PSORIASIS SKIN - INTERACTION OF ACTIVATED HLA-DR(+) IMMUNOCOMPETENT CELLS AND ENDOTHELIAL-CELLS IS A MAJOR FEATURE OF PSORIATIC LESIONS
    DEBOER, OJ
    VANDERLOOS, CM
    HAMERLINCK, F
    BOS, JD
    DAS, PK
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 1994, 286 (02) : 87 - 96
  • [9] CLEARANCE OF SEVERE PSORIASIS AFTER ALLOGENIC BONE-MARROW TRANSPLANTATION
    EEDY, DJ
    BURROWS, D
    BRIDGES, JM
    JONES, FGC
    [J]. BRITISH MEDICAL JOURNAL, 1990, 300 (6729) : 908 - 908
  • [10] ELEVATED TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) BIOLOGICAL-ACTIVITY IN PSORIATIC SKIN-LESIONS
    ETTEHADI, P
    GREAVES, MW
    WALLACH, D
    ADERKA, D
    CAMP, RDR
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 96 (01) : 146 - 151